What experimental approaches validate FLA16 antibody specificity in Arabidopsis studies?
Western blotting: FLA16-YFP fusion proteins were detected in microsomal membrane (MM SDS) and cell wall fractions using anti-GFP antibodies, with Plasma Membrane (PM) enrichment confirmed by anti-H+-ATPase blots .
Immunogold TEM: Anti-His antibody labeling showed FLA16 localization at plasma membranes (PM) and secondary cell walls (9.8 gold particles/μm² in PM vs. 0.6 in cytoplasm; p < 0.05) .
Negative controls: No labeling observed in WT or no-primary-antibody controls (Supplementary Figure S7) .
How does FLA16 deficiency alter secondary cell wall composition?
Cellulose reduction: fla16 mutants exhibit 9% less cellulose (linkage analysis) and 16% less crystalline cellulose (acetic/nitric assay) .
Glucuronoxylan increase: 10% higher glucuronoxylan content compared to WT (Figure 4A) .
Biomechanical impact: Reduced stem tensile strength and stiffness correlated with cellulose deficits .
How can contradictions in FLA16 localization data be resolved?
Fractionation challenges: FLA16 partitions into both Wall SDS (cell wall) and MM SDS (membrane) fractions due to its moderate glycosylation and lack of GPI anchoring .
Method triangulation: Combine:
Glycosylation effects: Partial deglycosylation improves antibody binding efficiency in wall-associated proteins .
What mechanistic insights link FLA16 to cellulose biosynthesis regulation?
Transcriptional regulation: fla16 mutants show 40% reduced CESA8 expression (Q-PCR, Figure 5C), critical for secondary cell wall cellulose .
Isoxaben sensitivity: fla16 hypocotyls are hypersensitive to cellulose synthase inhibitors (4.4x shorter vs. WT’s 3x under 2 nM isoxaben) .
Hypothesized signaling role: FLA16 may relay wall integrity signals via PM-associated receptor kinases (e.g., THESEUS1) .
Can computational models predict FLA16-antibody binding landscapes?
How do FLA16 orthologs vary in monocots vs. dicots?